NHS refuses pioneering breast cancer drug
New medication is deemed too expensive A revolutionary new drug called Kadcyla, used to treat very aggressive breast cancer, will not be available in England, as advisory body NICE declares it too expensive. Kadcyla is said to add an average of six months on to the life of a woman dying from HER2-positive breast cancer … [Read more…]